Effects of antipsychotic treatment on psychopathology and motor symptoms. A placebo-controlled study in healthy volunteers

被引：0
作者：
Tanja Veselinović
Holger Schorn
Ingo Vernaleken
Katharina Schiffl
Christoph Hiemke
Gerald Zernig
Ruben Gur
Gerhard Gründer
机构：
[1] RWTH Aachen University,Department of Psychiatry, Psychotherapy and Psychosomatics
[2] JARA—Translational Brain Medicine,Neuropsychiatry Division, Department of Psychiatry
[3] University of Pennsylvania and the Philadelphia Veterans Administration Medical Center,Institute of Medical Statistics
[4] RWTH Aachen University,Department of Psychiatry and Psychotherapy
[5] University Medical Centre Mainz,Experimental Psychiatry Unit, Department of Psychiatry and Psychotherapy
[6] Medical University Innsbruck,undefined
来源：
Psychopharmacology | 2011年 / 218卷
关键词：
Dopamine; Antipsychotics; Psychopathology; Healthy volunteers; Aripiprazole; Reserpine; Haloperidol;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：733 / 748
页数：15
相关论文
共 50 条
  • [31] Ziprasidone in the treatment of acute mania: a 12-week, placebo-controlled, haloperidol-referenced study
    Vieta, E.
    Ramey, T.
    Keller, D.
    English, P. A.
    Loebel, A. D.
    Miceli, J.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2010, 24 (04) : 547 - 558
  • [32] Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose-effect study
    Hasler, F
    Grimberg, U
    Benz, MA
    Huber, T
    Vollenweider, FX
    PSYCHOPHARMACOLOGY, 2004, 172 (02) : 145 - 156
  • [33] Antipsychotic Effects of Celecoxib Add-On Haloperidol in Schizophrenia: A Randomized Double-Blind Placebo-Controlled Clinical Trial
    Zarghami, Mehran
    Dodangi, Nasrin
    Azari, Paria
    Khalilian, Alireza
    IRANIAN JOURNAL OF PSYCHIATRY AND BEHAVIORAL SCIENCES, 2024, 18 (01)
  • [34] XG-102 administered to healthy male volunteers as a single intravenous infusion: a randomized, double-blind, placebo-controlled, dose-escalating study
    Deloche, Catherine
    Lopez-Lazaro, Luis
    Mouz, Sebastien
    Perino, Julien
    Abadie, Claire
    Combette, Jean-Marc
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2014, 2 (01): : 1 - 12
  • [35] Cognitive and negative symptoms in schizophrenia with L-Carnosine adjuvant therapy - A randomized double-blind placebo-controlled study
    Tharoor, Hema
    Maran, Sindhu
    Chandan, Antra K.
    Pari, Manikandan
    Rao, Shruti
    Durairaj, Jothilakshmi
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2023, 11 (02):
  • [36] Adjunctive Varenicline Treatment with Antipsychotic Medications for Cognitive Impairments in People with Schizophrenia: A Randomized Double-Blind Placebo-Controlled Trial
    Joo-Cheol Shim
    Do-Un Jung
    Sung-Soo Jung
    Young-Soo Seo
    Deuk-Man Cho
    Ji-Heon Lee
    Sae-Woom Lee
    Bo-Geum Kong
    Je-Wook Kang
    Min-Kyung Oh
    Sang-Duk Kim
    Robert P McMahon
    Deanna L Kelly
    Neuropsychopharmacology, 2012, 37 : 660 - 668
  • [37] Effect of add-on alpha lipoic acid on psychopathology in patients with treatment-resistant schizophrenia: a pilot randomized double-blind placebo-controlled trial
    Mishra, Archana
    Reeta, K. H.
    Sarangi, Sudhir Chandra
    Maiti, Rituparna
    Sood, Mamta
    PSYCHOPHARMACOLOGY, 2022, 239 (11) : 3525 - 3535
  • [38] Digestive tolerance of inulin-type fructans: a double-blind, placebo-controlled, cross-over, dose-ranging, randomized study in healthy volunteers
    Bruhwyler, Jacques
    Carreer, Fabienne
    Demanet, Etienne
    Jacobs, Heidi
    INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION, 2009, 60 (02) : 165 - 175
  • [39] Escitalopram in the treatment of negative symptoms in patients with chronic schizophrenia: A randomized double-blind placebo-controlled trial
    Iancu, Iulian
    Tschernihovsky, Eleonora
    Bodner, Ehud
    Piconne, Anna Sapir
    Lowengrub, Katherine
    PSYCHIATRY RESEARCH, 2010, 179 (01) : 19 - 23
  • [40] Lurasidone for the treatment of depressive symptoms in schizophrenia: analysis of 4 pooled, 6-week, placebo-controlled studies
    Nasrallah, Henry A.
    Cucchiaro, Josephine B.
    Mao, Yongcai
    Pikalov, Andrei A.
    Loebel, Antony D.
    CNS SPECTRUMS, 2015, 20 (02) : 140 - 147
12345